{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:28:00Z","timestamp":1790285280333,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The\n                    <jats:italic>RYR1<\/jats:italic>\n                    gene codes for a ryanodine receptor which is a calcium release channel in the skeletal muscle sarcoplasmic reticulum. It is associated with Malignant Hyperthermia (MH) and congenital myopathies including Central Core Disease (CCD), Multiminicore Disease (MMD) and Congenital Fibre-Type Disproportion (CFTD). There is currently little information on the epidemiology of\n                    <jats:italic>RYR1<\/jats:italic>\n                    variants in Asians. Our study aims to describe the\n                    <jats:italic>RYR1<\/jats:italic>\n                    variant landscape in a Singapore cohort unselected for\n                    <jats:italic>RYR1<\/jats:italic>\n                    -associated conditions. Data was retrieved from the SG10K pilot project, where whole genome sequencing was performed on volunteers unselected and undetermined for\n                    <jats:italic>RYR1<\/jats:italic>\n                    -associated conditions. Variants were classified based on pathogenicity using databases ClinVar and InterVar. Allele frequencies of pathogenic variants were compared between Chinese, Indians and Malays. Using databases ExAC, GnomAD and GenomeAsia 100k study, we further compared local allele frequencies to those in Europe, America and Asia. Data was analysed using R Commander. Significant\n                    <jats:italic>P<\/jats:italic>\n                    value was set at\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05. Majority of the\n                    <jats:italic>RYR1<\/jats:italic>\n                    variants were missense mutations. We identified four pathogenic and four likely pathogenic\n                    <jats:italic>RYR1<\/jats:italic>\n                    variants. All were related to the aforementioned\n                    <jats:italic>RYR1<\/jats:italic>\n                    -associated conditions. There were 6 carriers of\n                    <jats:italic>RYR1<\/jats:italic>\n                    pathogenic variants amongst 4810 individuals, corresponding to an allele frequency of 0.06%. The prevalence of pathogenic variants was the highest amongst Indians (4 in 1127 individuals) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.030). Majority of pathogenic and likely pathogenic mutations were missense and located in mutational hotspots. These variants also occurred at higher frequencies in Asians than globally. This study describes the variant landscape of the\n                    <jats:italic>RYR1<\/jats:italic>\n                    gene in Singapore. This knowledge will facilitate genetic screening for RYR1-related conditions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-09310-w","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:04:10Z","timestamp":1648706650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Variant landscape of the RYR1 gene based on whole genome sequencing of the Singaporean population"],"prefix":"10.1038","volume":"12","author":[{"given":"Claribel Tian Yu","family":"Foo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Hui","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Irwanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Yu-Jin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia Tsong Huey","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian Kah","family":"Ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"9310_CR1","volume-title":"RYR1 Ryanodine Receptor 1 [Homo sapiens (Human)]","author":"NCBI","year":"2020","unstructured":"NCBI. RYR1 Ryanodine Receptor 1 [Homo sapiens (Human)] (NCBI, 2020)."},{"key":"9310_CR2","unstructured":"Todd, J. J., Goldberg, M. F., Dirksen, R. T. & Voermans, N. C. RYR1-Related Diseases. https:\/\/rarediseases.org\/rare-diseases\/ryr-1-related-diseases\/ (2021)."},{"key":"9310_CR3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","volume":"121","author":"DM Miller","year":"2018","unstructured":"Miller, D. M. et al. Genetic epidemiology of malignant hyperthermia in the UK. Br. J. Anaesth. 121, 944\u2013952. https:\/\/doi.org\/10.1016\/j.bja.2018.06.028 (2018).","journal-title":"Br. J. Anaesth."},{"key":"9310_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg, H., Pollock, N., Schiemann, A., Bulger, T. & Stowell, K. Malignant hyperthermia: A review. Orphanet J. Rare Dis. 10, 93. https:\/\/doi.org\/10.1186\/s13023-015-0310-1 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"9310_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4097\/kjae.2012.63.5.391","volume":"63","author":"D-C Kim","year":"2012","unstructured":"Kim, D.-C. Malignant hyperthermia. Korean J. Anesthesiol. 63, 391\u2013401. https:\/\/doi.org\/10.4097\/kjae.2012.63.5.391 (2012).","journal-title":"Korean J. Anesthesiol."},{"key":"9310_CR6","first-page":"60","volume":"46","author":"DWY Li","year":"2017","unstructured":"Li, D. W. Y., Lai, P. S., Lee, D. W., Yong, R. Y. Y. & Lee, T. L. Malignant hyperthermia and ryanodine receptor type 1 gene (RyR1) mutation in a family in Singapore. Ann. Acad. Med. 46, 60 (2017).","journal-title":"Ann. Acad. Med."},{"key":"9310_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson, R., Carpenter, D., Shaw, M. A., Halsall, J. & Hopkins, P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat. 27, 977\u2013989. https:\/\/doi.org\/10.1002\/humu.20356 (2006).","journal-title":"Hum. Mutat."},{"key":"9310_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","volume":"8","author":"S Treves","year":"2008","unstructured":"Treves, S., Jungbluth, H., Muntoni, F. & Zorzato, F. Congenital muscle disorders with cores: The ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol. 8, 319\u2013326. https:\/\/doi.org\/10.1016\/j.coph.2008.01.005 (2008).","journal-title":"Curr. Opin. Pharmacol."},{"key":"9310_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","volume":"128","author":"S Riazi","year":"2018","unstructured":"Riazi, S., Kraeva, N. & Hopkins, P. M. Malignant hyperthermia in the post-genomics era: New perspectives on an old concept. Anesthesiology 128, 168\u2013180. https:\/\/doi.org\/10.1097\/ALN.0000000000001878 (2018).","journal-title":"Anesthesiology"},{"key":"9310_CR10","unstructured":"Litman, R. S. in UpToDate (ed Stephanie B Jones) (UpToDate, 2019)."},{"key":"9310_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-2-31","volume":"2","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth, H. Multi-minicore disease. Orphanet J. Rare Dis. 2, 31\u201331. https:\/\/doi.org\/10.1186\/1750-1172-2-31 (2007).","journal-title":"Orphanet J. Rare Dis."},{"key":"9310_CR12","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awm096","volume":"130","author":"H Zhou","year":"2007","unstructured":"Zhou, H. et al. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain 130, 2024\u20132036. https:\/\/doi.org\/10.1093\/brain\/awm096 (2007).","journal-title":"Brain"},{"key":"9310_CR13","unstructured":"MedGen. (NCBI)."},{"key":"9310_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","volume":"128","author":"RS Litman","year":"2018","unstructured":"Litman, R. S., Griggs, S. M., Dowling, J. J. & Riazi, S. Malignant hyperthermia susceptibility and related diseases. Anesthesiology 128, 159\u2013167. https:\/\/doi.org\/10.1097\/ALN.0000000000001877 (2018).","journal-title":"Anesthesiology"},{"key":"9310_CR15","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/brain\/awl077","volume":"129","author":"S Wu","year":"2006","unstructured":"Wu, S. et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 129, 1470\u20131480 (2006).","journal-title":"Brain"},{"key":"9310_CR16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","volume":"104","author":"CA Ibarra M","year":"2006","unstructured":"Ibarra M, C. A. et al. Malignant hyperthermia in Japan: Mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 104, 1146\u20131154 (2006).","journal-title":"Anesthesiology"},{"key":"9310_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","volume":"119","author":"SG Gonsalves","year":"2013","unstructured":"Gonsalves, S. G. et al. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology 119, 1043\u20131053. https:\/\/doi.org\/10.1097\/ALN.0b013e3182a8a8e7 (2013).","journal-title":"Anesthesiology"},{"key":"9310_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2019.09.019","volume":"179","author":"D Wu","year":"2019","unstructured":"Wu, D. et al. Large-scale whole-genome sequencing of three diverse Asian populations in Singapore. Cell 179, 736-749.e715. https:\/\/doi.org\/10.1016\/j.cell.2019.09.019 (2019).","journal-title":"Cell"},{"key":"9310_CR19","unstructured":"ClinVar and ClinGen. https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/docs\/clingen\/."},{"key":"9310_CR20","unstructured":"NCBI. ClinVar and ClinGen. https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/docs\/clingen\/."},{"key":"9310_CR21","unstructured":"Clinical Interpretation of Genetic Variants by ACMG\/AMP 2015 Guideline. https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/docs\/clingen\/."},{"key":"9310_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2015","unstructured":"Li, Q. & Wang, K. InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP Guidelines. Am. J. Hum. Genet. 100, 267\u2013280. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.004 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"9310_CR23","unstructured":"ExAC. ExAC Browser. http:\/\/exac.broadinstitute.org\/."},{"key":"9310_CR24","unstructured":"gnomAD. gnomAD. https:\/\/gnomad.broadinstitute.org\/."},{"key":"9310_CR25","unstructured":"GenomeAsia. GenomeAsia 100k. https:\/\/genomeasia100k.org\/."},{"key":"9310_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291. https:\/\/doi.org\/10.1038\/nature19057 (2016).","journal-title":"Nature"},{"key":"9310_CR27","unstructured":"Laurent Francioli, G. T., Karczewski, K., Solomonson, M. & Watts, N. gnomAD v2.1. https:\/\/macarthurlab.org\/2018\/10\/17\/gnomad-v2-1\/ (2018)."},{"key":"9310_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-019-1793-z","volume":"576","author":"Consortium, G. K.","year":"2019","unstructured":"Consortium, G. K. The GenomeAsia 100K Project enables genetic discoveries across Asia. Nature 576, 106\u2013111. https:\/\/doi.org\/10.1038\/s41586-019-1793-z (2019).","journal-title":"Nature"},{"key":"9310_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0310057x0803600311","volume":"36","author":"RL Gillies","year":"2008","unstructured":"Gillies, R. L., Bjorksten, A. R., Davis, M. & Du Sart, D. Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots. Anaesth. Intensive Care 36, 391\u2013403. https:\/\/doi.org\/10.1177\/0310057x0803600311 (2008).","journal-title":"Anaesth. Intensive Care"},{"key":"9310_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1212\/01.wnl.0000188870.37076.f2","volume":"27","author":"H Jungbluth","year":"2005","unstructured":"Jungbluth, H. et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 27, 12. https:\/\/doi.org\/10.1212\/01.wnl.0000188870.37076.f2 (2005).","journal-title":"Neurology"},{"key":"9310_CR31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/humu.20696","volume":"29","author":"N Monnier","year":"2008","unstructured":"Monnier, N. et al. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum Mutat 29, 670\u2013678. https:\/\/doi.org\/10.1002\/humu.20696 (2008).","journal-title":"Hum Mutat"},{"key":"9310_CR32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/humu.22056","volume":"33","author":"A Klein","year":"2012","unstructured":"Klein, A. et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum Mutat 33, 981\u2013988. https:\/\/doi.org\/10.1002\/humu.22056 (2012).","journal-title":"Hum Mutat"},{"key":"9310_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1152\/physiolgenomics.00126.2016","volume":"49","author":"TA Beam","year":"2016","unstructured":"Beam, T. A., Loudermilk, E. F. & Kisor, D. F. Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia. Physiol. Genom. 49, 81\u201387. https:\/\/doi.org\/10.1152\/physiolgenomics.00126.2016 (2016).","journal-title":"Physiol. Genom."},{"key":"9310_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-981-10-7757-9_11","volume":"87","author":"G Santulli","year":"2018","unstructured":"Santulli, G., Lewis, D., van Georges, A., Marks, A. R. & Frank, J. Ryanodine receptor structure and function in health and disease. Subcell Biochem. 87, 329\u2013352. https:\/\/doi.org\/10.1007\/978-981-10-7757-9_11 (2018).","journal-title":"Subcell Biochem."},{"key":"9310_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1750-1172-8-117","volume":"8","author":"K Amburgey","year":"2013","unstructured":"Amburgey, K. et al. Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet J. Rare Dis. 8, 117. https:\/\/doi.org\/10.1186\/1750-1172-8-117 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"9310_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00109-005-0638-4","volume":"83","author":"Q Wang","year":"2005","unstructured":"Wang, Q. et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J. Mol. Med. (Berl) 83, 203\u2013208. https:\/\/doi.org\/10.1007\/s00109-005-0638-4 (2005).","journal-title":"J. Mol. Med. (Berl)"},{"key":"9310_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","volume":"15","author":"S Treves","year":"2005","unstructured":"Treves, S. et al. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord. 15, 577\u2013587. https:\/\/doi.org\/10.1016\/j.nmd.2005.06.008 (2005).","journal-title":"Neuromuscul. Disord."},{"key":"9310_CR38","doi-asserted-by":"crossref","unstructured":"Yuchi, Z., Kimlicka, L. & Van, F. Structural Insights into Disease Mutations of the Ryanodine Receptor (2013).","DOI":"10.5772\/53641"},{"key":"9310_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nature13950","volume":"517","author":"R Zalk","year":"2015","unstructured":"Zalk, R. et al. Structure of a mammalian ryanodine receptor. Nature 517, 44\u201349. https:\/\/doi.org\/10.1038\/nature13950 (2015).","journal-title":"Nature"},{"key":"9310_CR40","unstructured":"NCBI. (NCBI, 2019)."},{"key":"9310_CR41","unstructured":"Girard, T. Testing for MH Susceptibility. https:\/\/www.emhg.org\/testing-for-mh (2015)."},{"key":"9310_CR42","first-page":"212","volume":"100","author":"TE Nelson","year":"2004","unstructured":"Nelson, T. E., Rosenberg, H. & Muldoon, S. M. Genetic testing for malignant hyperthermia in North America. Anesthesiol. J. Am. Soc. Anesthesiol. 100, 212\u2013214 (2004).","journal-title":"Anesthesiol. J. Am. Soc. Anesthesiol."},{"key":"9310_CR43","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/gim.2014.156","volume":"17","author":"CS Bennette","year":"2015","unstructured":"Bennette, C. S., Gallego, C. J., Burke, W., Jarvik, G. P. & Veenstra, D. L. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing. Genet. Med. 17, 587\u2013595. https:\/\/doi.org\/10.1038\/gim.2014.156 (2015).","journal-title":"Genet. Med."},{"key":"9310_CR44","unstructured":"ClinGen. Variant: NM_001042723.2(RYR1):c.2654G>A (p.Arg885His). https:\/\/erepo.clinicalgenome.org\/evrepo\/ui\/interpretation\/75f6a216-0fff-441e-a01f-0c9a73ffa399."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09310-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:18:07Z","timestamp":1669321087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09310-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9310"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09310-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.11.21261947","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.I. is an employee of Nalagenetics Pte Ltd. A.I. and J.L. has financial holdings in Nalagenetics Pte Ltd. The rest of the authors do not have any conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5429"}}